Welcure Drugs & Pharmaceuticals Ltd (NSE: WELCURE), ISIN INE331C01025 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
WELCURE last traded at ₹0.24 (+0.00%), with a 52-week range of ₹0.23 to ₹1.18 (as of 29 Jul 2026).
Shareholding as of Dec 2025: promoters 0.00%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 36/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.